GIP Receptor Activation GIP receptor agonism provides additive metabolic effects that are not achievable with GLP-1 alone
Flare cycles diminish
This interaction neutralizes phosphatase activity and releases SnRK2, which phosphorylates multiple targets, including ABF/AREB transcription factors, ROS-producing oxidases (RBOHs), and ion channels (Wang et al
Side Effects Comparison Since both medications affect gut hormones and slow gastric emptying, they cause similar side effects
Oral pills, conversely, must navigate the digestive system, resulting in significantly lower absorption rates (estimated at 1-2%)
Understanding whether tirzepatide directly causes these symptomsor if they result from dehydration, metabolic changes, or concurrent illnessis essential for appropriate management